Cancer surgery: Risks and opportunities

BioEssays

Volumn 28, Issue 4, 2006, Pages 433-437

  Coffey, J C ^a   Smith, M J F ^a   Wang, J H ^a   Bouchier Hayes, D ^b   Cotter, T G ^a   Redmond, H P ^a  

^a University College Cork and INFANT Centre   (Ireland)

^b ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; ANGIOGENESIS INHIBITOR; BONE DERIVED GROWTH FACTOR; CYCLOOXYGENASE 2 INHIBITOR; CYCLOPHOSPHAMIDE; FLUOROURACIL; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; PLATELET DERIVED GROWTH FACTOR; PROBIOTIC AGENT; TAUROLIDINE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

BREAST CANCER; CANCER GROWTH; CANCER RECURRENCE; CANCER RISK; CANCER SURGERY; DRUG INHIBITION; DRUG MECHANISM; HUMAN; LAPAROTOMY; METASTASIS; PERIOPERATIVE PERIOD; REVIEW;

HUMANS; NEOPLASM, RESIDUAL; NEOPLASMS; POSTOPERATIVE PERIOD; RISK FACTORS;

EID: 33645827554     PISSN: 02659247     EISSN: None     Source Type: Journal    
DOI: 10.1002/bies.20381     Document Type: Review

References (69)

1. Coffey JC, Wang JH, Bouchier-Hayes D, Cotter TG, Redmond HP. 2005. Coming back at you with Pi3 kinase. Science Stke Vol 2005:tw213.
2. Tagliabue E, Agresti R, Carcangiu ML, et al. 2003. Role of HER2 in wound-induced breast carcinoma proliferation. The Lancet 362:527-533.
3. Spigel DR. 2003. HER2 and surgery: more questions to answer. The Lancet 362:502.
4. Coffey JC, Wang JH, Cotter TG, Redmond HP. 2003. Excisional surgery for cancer cure-therapy at a cost. The Lancet Oncology 4:760-768.
5. Coffey JC, Wang JH, Smith MJ, et al. 2005. Phosphoinositide 3 kinase accelerates postperative tumor growth by inhibiting apoptosis and enhancing resitance to chemotherapy-induced apoptosis-novel role for an old enemy. The Journal of Biological Chemistry 98:20968-20977.
6. Baum M, Demicheli R, Hrushesky W, Restky M. 2005. Does surgery unfavourably perturb the "natural history" of early bresat cancer by accelerating the appearance of distant metastases? European Journal of Cancer 41:508-515.
7. Ellis H. 2001. A history of surgery. London: Greenwich Medical Media.
8. Tyzzer E. 1913. Factors in the production and growth of tumour metastases. Journal of Medical Resarch 28:309-322.
9. Skipper D, Jeffrey MJ, Cooper AJ, Taylor I, Alexander P. 1988. Preferential growth of bloodborne cancer cells in colonic anastomoses. Br J Cancer 57:564-568.
10. Skipper D, Jeffrey MJ, Cooper AJ, Alexander P, Taylor I. 1989. Enhanced growth of tumour cells in healing colonic anastomoses and laparotomy wounds. Int J Colorectal Dis 4:172-177.
11. Jones F, Rous P. 1914. On the localisation of secondary tumour at points of injury. Monograph of the Rockefeller Institute for Medical Research 1:404-412.
12. Abramovitch R, Marikovsky M, Meir G, Neeman M. 1999. Stimulation of tumour growth by wound-derived growth factors. Br J Cancer 79:1392-1398.
13. Chang JC, Wooten EC, Tsimelzon A, et al. 2003. Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer. Lancet 362:362-369.
14. Dvorak HF. 1986. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med 315:1650-1659.
15. Coussens LM, Werb Z. 2002. Inflammation and cancer. Nature 420:860-867.
16. Hofer SO, Shrayer D, Reichner JS, et al. 1998. Wound-induced tumor progression: a probable role in recurrence after tumor resection. Arch Surg 133:383-389.
17. Stocchi L, Nelson H. 2000. Wound recurrences following laparoscopic-assisted colectomy for cancer. Arch Surg 135:948-958.
18. Read TE, Mutch MG, Chang BW, et al. 2002. Locoregional recurrence and survival after curative resection of adenocarcinoma of the colon. J Am Coll Surg 195:33-40.
19. Mitsudomi T, Nishioka K, Maruyama R, et al. 1996. Kinetic analysis of recurrence and survival after potentially curative resection of nonsmall cell lung cancer. J Surg Oncol 63:159-165.
20. Flintoft L. 2003. Breast Cancer: Recurrence. Nature Reviews: Cancer.
21. Demicheli R. 2001. Tumour dormancy: findings and hypotheses from clinical research on breast cancer. Semin Cancer Biol 11:297-306.
22. Clare SE, Nakhlis F, Panetta JC. 2000. Molecular biology of breast cancer metastasis. The use of mathematical models to determine relapse and to predict response to chemotherapy in breast cancer. Breast Cancer Res 2:430-435.
23. Karrison TG, Ferguson DJ, Meier P. 1999. Dormancy of mammary carcinoma after mastectomy. J Natl Cancer Inst 91:80-85.
24. Demicheli R, Miceli R, Valagussa P, Bonadonna G. 2000. Re: Dormancy of mammary carcinoma after mastectomy. J Natl Cancer Inst 92:347-348.
25. Varani J, Lovett EJ 3rd, Lundy J. 1981. A model of tumor cell dormancy: effects of anesthesia and surgery. J Surg Oncol 17:9-14.
26. Holmgren L, O'Reilly MS, Folkman J. 1995. Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat Med 1:149-153.
27. Lange PH, Hekmat K, Bosl G, Kennedy BJ, Fraley EE. 1980. Accelerated growth of testicular cancer after cytoreductive surgery. Cancer 45:1498-1506.
28. Hoskins WJ. 1989. The influence of cytoreductive surgery on the progression-free interval and survival in epithelial and ovarian cancer. Ballieres Clinical Obstetrics and Gynaecology 3:59-71.
29. deVere White R, Deitch AD, Hong WK, Olsson CA. 1985. The influence of cytoreductive surgery on the response to chemotherapy of a rat renal cancer. Urol Res 13:35-38.
30. Demicheli R, Valagussa P, Bonadonna G. 2001. Does surgery modify growth kinetics of breast cancer micrometastases? Br J Cancer 85:490-492.
31. Gutt CN, Riemer V, Kim ZG, Erceg J, Lorenz M. 2001. Impact of laparoscopic surgery on experimental hepatic metastases. Br J Surg 88:371-375.
32. Gutt CN, Kim ZG, Schmandra T, Paolucci V, Lorenz M. 2000. Carbon dioxide pneumoperitoneum is associated with increased liver metastases in a rat model. Surgery 127:566-570.
33. Tubiana M. 1986. The growth and progression of human tumors: implications for management strategy. Radiotherapy Oncology 6:167-184.
34. Shin M, Ueki K, Kurita H, Kirino T. 2002. Malignant transformation of a vestibular schwannoma after gamma knife radiosurgery. Lancet 360: 309-310.
35. Lacy AM, Garcia-Valdecasas JC, Delgado S, et al. 2002. Laparoscopy-assisted colectomy versus open colectomy for treatment of non-metastatic colon cancer: a randomised trial. Lancet 359:2224-2229.
36. Macadam R, Sarela A, Wilson J, MacLennan K, Guillou P. 2003. Bone marrow micrometastases predict early post-operative recurrence following surgical resection of oesophageal and gastric carcinoma. Eur J Surg Oncol 29:450-454.
37. Early Breast Cancer Trialists' Collaborative Group. 1998. Polychemotherapy for early breast cancer: an overview of the randomised trials. Lancet 352:930-942.
38. Early Breast Cancer Trialists Collaborative Group. 1998. Tamoxifen for early breast cancer: an overview of the randomised trials. Lancet 352:1451-1467.
39. Nissen-Meyer R, Kjellgren K, Malmio K, Mansson B, Norin T. 1978. Surgical adjuvant chemotherapy: results with one short course with cyclophosphamide after mastectomy for breast cancer. Cancer 41:2088-2098.
40. Sertoli MR, Bruzzi P, Pronzato P, et al. 1995. Randomized cooperative study of perioperative chemotherapy in breast cancer. J Clin Oncol 13:2712-2721.
41. The Cancer Research Campaign Adjuvant Trials Group. 1992. The effects of adjuvant tamoxifen: the latest results from the Cancer Research Campaign Adjuvant trials group. European Journal of Cancer 28a:904-907.
42. Arai K, Asakura T, Nemir P Jr. 1992. Effect of local tumor removal and retained oncolysate on lung metastasis. J Surg Res 53:30-38.
43. Bouvy ND, Marquet RL, Jeekel H, Bonjer HJ. 1996. Impact of gas(less) laparoscopy and laparotomy on peritoneal tumor growth and abdominal wall metastases. Ann Surg 224:694-701.
44. Bouvy ND, Marquet RL, Jeekel J, Bonjer HJ. 1997. Laparoscopic surgery is associated with less tumour growth stimulation than conventional surgery: an experimental study. Br J Surg 84:358-361.
45. Coffey JC, Wang JH, Cotter TG, Redmond HP. 2003. Cytoreductive surgery enhances tumor growth by downregulating mitochondrial apoptosis. Ann Surg One 10:54.
46. Coffey JC, Wang JH, Cotter TG, Redmond HP. 2003. Inhibition of phosphatidylinositol-3 kinase abrogates tumour acceleration following cytoreductive surgery. Br J Surg 90:617.
47. Da Costa ML, Redmond HP, Bouchier-Hayes DJ. 2001. Taurolidine improves survival by abrogating the accelerated development and proliferation of solid tumors and development of organ metastases from circulating tumor cells released following surgery. J Surg Res 101:111-119.
48. Da Costa ML, Redmond HP, Finnegan N, Flynn M, Bouchier-Hayes D. 1998. Laparotomy and laparoscopy differentially accelerate experimental flank tumour growth. Br J Surg 85:1439-1442.
49. Da Costa ML, Redmond P, Bouchier-Hayes DJ. 1998. The effect of laparotomy and laparoscopy on the establishment of spontaneous tumor metastases. Surgery 124:516-525.
50. O'Reilly MS, Boehm T, Shing Y, et al. 1997. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 88:277-285.
51. O'Reilly MS, Holmgren L, Shing Y, et al. 1994. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 79:315-328.
52. Pidgeon GP, Barr MP, Harmey JH, Foley DA, Bouchier-Hayes DJ. 2001. Vascular endothelial growth factor (VEGF) upregulates BCL-2 and inhibits apoptosis in human and murine mammary adenocarcinoma cells. Br J Cancer 85:273-278.
53. Pidgeon GP, Harmey JH, Kay E, Da Costa M, Redmond HP, Bouchier-Hayes DJ. 1999. The role of endotoxin/lipopolysaccharide in surgically induced tumour growth in a murine model of metastatic disease. Br J Cancer 81:1311-1317.
54. Harmey JH, Bucana CD, Lu W, et al. 2002. Lipopolysaccharide-induced metastatic growth is associated with increased angiogenesis, vascular permeability and tumor cell invasion. Int J Cancer 101:415-422.
55. Gutt CN, Riemer V, Kim ZG, Jacobi CA, Paolucci V, et al. 1999. Impact of laparoscopic colonic resection on tumour growth and spread in an experimental model. Br J Surg 86:1180-1184.
56. Cao Y, O'Reilly MS, Marshall B, Flynn E, Ji RW, Folkman J. 1998. Expression of angiostatin cDNA in a murine fibrosarcoma suppresses primary tumor growth and produces long-term dormancy of metastases. J Clin Invest 101:1055-1063.
57. Wang JH, Manning BJ, Wu QD, Blankson S, Bouchier-Hayes D, et al. 2003. Endotoxin/lipopolysaccharide activates NF-kappa B and enhances tumor cell adhesion and invasion through a beta 1 integrin-dependent mechanism. J Immunol 170:795-804.
58. Simpson-Herren L, Sanford AH, Holmquist JP. 1976. Effects of surgery on the cell kinetics of residual tumor. Cancer Treat Rep 60:1749-1760.
59. Maniwa Y, Kanki M, Okita Y. 2000. Importance of the control of lung recurrence soon after surgery of pulmonary metastases. Am J Surg 179:122-125.
60. Coffey JC, Wang JH, Cotter TG, Redmond HP. 2002. Bacterial Antigens Differentially Regulate Tumour Cell Apoptosis. Journal of Endotoxin Research Abstract.
61. Brivio F, Lissoni P, Alderi G, Barni S, Lavorato F, et al. 1996. Preoperative interleukin-2 subcutaneous immunotherapy may prolong the survival time in advanced colorectal cancer patients. Oncology 53:263-268.
62. Brivio F, Lissoni P, Rovelli F, et al. 2002. Effects of IL-2 preoperative immunotherapy on surgery-induced changes in angiogenic regulation and its prevention of VEGF increase and IL-12 decline. Hepatogastroenterology 49:385-387.
63. Coffey JC, Wang JH, Bouchier-Hayes D, Cotter TG, Redmond HP. 2004. CUH-1 - a novel dendritic cell vaccine that protects against the potentiating effects of perioperative tumour growth. Brit J Surg 91:1211-1213.
64. Veronesi U, Luini A, Mariani L, et al. 1994. Effect of menstrual phase on surgical treatment of breast cancer. Lancet 343:1545-1547.
65. Iisted N. 1988. Cyclophosphamide and tamoxifen as adjuvant therapies in te treatment of breast cancer. Br J Cancer 57:604-607.
66. van der Hage JA, van de Velde CJ, Julien JP, et al. 2001. Improved survival after one course of perioperative chemotherapy in early breast cancer patients, long-term results from the European Organization for Research and Treatment of Cancer (EORTC) Trial 10854. Eur J Cancer 37:2184-2193.
67. Qadri S, Wang JH, Coffey JC, et al. 2005. Surgically Induced Accelerated Local And Distant Tumor Growth Is Significantly Attenuated By Selective COX-2 Inhibition. Annals of Thoracic Surgery 79:990-995.
68. Qadri S, Wang JH, Redmond HP. 2003. Cox-2 inhibition decrease recurrent lung tumour growth. Irish journal of Medical Science 172:13.
69. Connolly EM, Harmey JH, O'Grady T, et al. 2002. Cyclo-oxygenase inhibition reduces tumour growth and metastasis in an orthotopic model of breast cancer. Br J Cancer 87:231-237.